Literature DB >> 27142854

Is ileal pouch-anal anastomosis after Whipple procedure doable?

C Benlice1, E Gorgun2.   

Abstract

Mesh：

Year:  2016        PMID： 27142854     DOI： 10.1007/s10151-016-1472-0

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  10 in total

1.  Colonic mucosal proliferation is related to serum deoxycholic acid levels.

Authors:  T Ochsenkühn; E Bayerdörffer; A Meining; M Schinkel; C Thiede; V Nüssler; M Sackmann; R Hatz; A Neubauer; G Paumgartner
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 3.  Primary sclerosing cholangitis.

Authors:  Y M Lee; M M Kaplan
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

4.  The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.

Authors:  K Shetty; L Rybicki; A Brzezinski; W D Carey; B A Lashner
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

5.  Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.

Authors:  Emre Gorgun; Feza H Remzi; Elena Manilich; Miriam Preen; Bo Shen; Victor W Fazio
Journal:  Surgery       Date:  2005-10       Impact factor: 3.982

6.  Cholangiocarcinoma complicating primary sclerosing cholangitis.

Authors:  C B Rosen; D M Nagorney; R H Wiesner; R J Coffey; N F LaRusso
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

7.  Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  Kelly Burak; Paul Angulo; Tousif M Pasha; Kathleen Egan; Jan Petz; Keith D Lindor
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

8.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

9.  Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.

Authors:  Roy M Soetikno; Otto S Lin; Paul A Heidenreich; Harvey S Young; Michael O Blackstone
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427

10.  High lifetime risk of cancer in primary sclerosing cholangitis.

Authors:  Marian M H Claessen; Frank P Vleggaar; Kristien M A J Tytgat; Peter D Siersema; Henk R van Buuren
Journal:  J Hepatol       Date:  2008-10-14       Impact factor: 25.083
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.